Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000899243-22-028141

Chief Commercial Officer sold 20,000 shares at an average $45.12 ($902,400)

  • Chief Commercial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-08-05 Exercise or conversion : show line 1 in the form +10,000 $2.21 $22,100 11,300 D
2022-08-05 Sale : show line 2 in the form −10,000 $45.16 $451,600 1,300 D
2022-08-05 Sale : show line 3 in the form −10,000 $45.08 $450,800 34,776 I
Open-market sales · 20,000 sh · avg $45.12 · $902,400

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-08-05 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −10,000 31,051 D
Loading xslF345X03/doc4.xml…